Literature DB >> 982756

The effect of xylazine upon hepatic glucose production and blood flow rate in the lactating dairy cow.

H W Symonds.   

Abstract

The effect of xylazine (Rompun) upon hepatic glucose production and blood flow rate was measured in two cows. Doses of 0-16 or 0-18 mg/kg bodyweight increased blood glucose concentrations by 200 per cent and hepatic glucose production by 400 per cent. Maximum blood glucose concentrations were reached approximately 40 minutes after dosing and did not start to fall until 185 minutes. Concentrations were near normal 24 hours after dosing. The increase in hepatic glucose production was greatest 20 minutes after dosing and production had returned to control rates 150 minutes after dosing. Visceral glucose utilisation was also increased. Blood flow rates in the hepatic and portal veins were reduced to 50 to 60 per cent of their predosing values. It is concluded that the prolonged hyperglycaemia which persists beyond 150 minutes is produced either by continued glucose production from sites other than liver and viscera or by reduced utilisation of the blood glucose by peripheral tissue.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 982756     DOI: 10.1136/vr.99.12.234

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  3 in total

1.  Plasma glucose concentration is maintained during TSE infection of cattle and sheep.

Authors:  R A Horton; G G Allison; D Jayasena; P Rees Stevens; D Clifford; S Everest; R Jackman; J M Moorby
Journal:  Vet Res Commun       Date:  2007-09-06       Impact factor: 2.459

2.  Is the glycogenolytic effect of clonidine mediated by alpha 2-adrenergic receptors?

Authors:  W H Hsu
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

3.  Effect of clonidine on glucose, insulin and glucagon responses to a protein meal in type 2 diabetics.

Authors:  S Ferlito; G Indelicato; S Di Vincenzo; F Del Campo; A La Vignera; C Fichera
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.